Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Toxicology Launches Mitragynine ELISA

Published: Friday, April 12, 2013
Last Updated: Friday, April 12, 2013
Bookmark and Share
New ELISA for the detection of designer drug Kratom.

Kratom is a designer drug which originates from Mitragyna speciosa; an uncontrolled plant found in South East Asia.

The designer drug has gained significant popularity in recent years due to its widespread availability on the internet and in head shops.

It is marketed as a way to combat fatigue, pain and depression. The new ELISA developed by Randox Toxicology is the world’s first immunoassay drug test for Kratom; providing a rapid solution for the detection of Mitragynine and its metabolites.

As with other designer drugs ‘Spice’ and ‘Bath Salts,’ ‘Kratom’ is marketed as a “legal high,” which can mislead users to believe that the drug is safe to use.

In fact, several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion.

Mitragynine and several related alkaloids naturally occur in the Mitragyna speciosa plant, creating psychoactive properties.

From exotic plants to synthetic blends; designer drugs create a difficult task for forensic toxicologists as waves of new compounds with differing chemical properties quickly flood the market.

Immunoassays provide a straightforward method for laboratory drug screening, allowing a large number of specimens can be screened relatively quickly.

The novel ELISA developed by Randox Toxicology can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.

Leading research and development capabilities has allowed Randox Toxicology to quickly respond to the need for reliable assays to detect designer drugs.

The UK manufacturer has developed a range of rapid immunoassays on ELISA and Biochip arrays, including Synthetic Cannabinoids and Synthetic Cathinones commonly referred to as ‘Bath Salts.’


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!